Toxins as Drugs: What Does the Future Hold?: Editorial
暂无分享,去创建一个
[1] M. Greaves,et al. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A , 1984 .
[2] Nissen Mb. Streptokinase therapy in acute myocardial infarction. , 1984 .
[3] D. Neville,et al. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow. , 1984, Journal of immunology.
[4] S. Aamdal,et al. Phase I study of the plant protein ricin. , 1984, Cancer research.
[5] J. N. Islam. THE FAR FUTURE OF THE UNIVERSE , 1984 .
[6] C. Vaughn,et al. Phase II evaluation of anguidine in central nervous system tumors: a southwest Oncology Group study. , 1983, Cancer treatment reports.
[7] S. Buzzi. Diphtheria toxin treatment of human advanced cancer. , 1982, Cancer research.
[8] Nauts Hc. Bacterial pyrogens: beneficial effects on cancer patients. , 1982 .
[9] J. Thigpen,et al. Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group Study. , 1981, Cancer treatment reports.
[10] A. B. Scott,et al. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. , 1980, Ophthalmology.
[11] M. Charlton,et al. Huntington'S disease: Treatment with muscimol, A GABA‐mimetic drug , 1978, Annals of neurology.